Identification of four novel polymorphisms in the Aα and γ fibrinogen genes and analysis of association with plasma levels of the protein

Thrombosis Research

Volumn 103, Issue 4, 2001, Pages 299-307

  Menegatti, M ^a   Asselta, R ^a   Duga, S ^a   Malcovati, M ^a   Bucciarelli, P ^a   Mannucci, P M ^a   Tenchini, M L ^a  

^a Dipartimento di Biologia   (Italy)

Author keywords

Cardiovascular disease; DNA polymorphism; Fibrinogen; Fibrinogen gene cluster; Vascular risk marker

Indexed keywords

FIBRINOGEN; PROTEIN;

ADULT; AGED; AGING; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA FLANKING REGION; DNA POLYMORPHISM; DRINKING BEHAVIOR; FEMALE; GENE CLUSTER; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; ITALY; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING;

EID: 0035880859     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00329-2     Document Type: Article

References (36)

1. Fibrinogen structure and fibrin clot assembly
2. Characterization of the 5′-flanking region of the gene for the α chain of human fibrinogen
3. The human β fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element
4. Characterization of the 5′-flanking region of the gene for the γ chain of human fibrinogen
5. Identification of a glucocorticoid response element in the human γ chain fibrinogen promoter
6. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies
7. Fibrinogen as a risk factor for stroke and myocardial infarction
8. Fate of fibrinogen in human arterial intima
9. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
10. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
11. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study
12. Bcl I polymorphism in the fibrinogen beta-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients
13. The identification of a DNA polymorphism of the alpha fibrinogen gene, and the regional assignment of the human fibrinogen genes to 4q26-qter
14. Linkage disequilibrium of RFLP's at the beta fibrinogen (FGB) and gamma fibrinogen (FGG) loci on chromosome 4
15. A multipoint genetic map and new RFLP's for human chromosome 4
16. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers
17. Tetranucleotide repeat polymorphism at the human alpha fibrinogen locus (FGA)
18. Human fibrinogen polymorphic site analysis by restriction endonuclease digestion and allele-specific polymerase chain reaction amplification: Identification of polymorphisms at positions A alpha 312 and B beta 448
19. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A -455 (HaeIII), C/T-148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fibrinogen) and TaqI (alpha-fibrinogen), and their detection by PCR
20. Two common functional polymorphisms in the promoter region of the β-fibrinogen gene contribute to regulation of plasma fibrinogen concentration
21. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations
22. Fibrinogen polymorphisms are not associated with the risk of myocardial infarction
23. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
24. The association of combined α and β fibrinogen genotype on plasma fibrinogen levels in smokers and non smokers
25. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion
26. Recommendations for a nomenclature system for human gene mutations
27. Effect on transcription of two common genetic polymorphisms adjacent to the promoter region of the β-fibrinogen gene
28. Genetic variation in human Bβ fibrinogen gene promoter influences formation of specific DNA-protein complex with the interleukin 6 response element
29. European atherosclerosis research study: Genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction
30. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden
31. Positive association of the β fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction
32. A common mutation (G-455 → A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9127 individuals based on The Copenhagen City Heart Study
33. Fibrinogen plasma levels in an apparently healthy general population - Relation to environmental and genetic determinants
34. Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update